======= POLE2 ======= == Gene Information == * **Official Symbol**: POLE2 * **Official Name**: DNA polymerase epsilon 2, accessory subunit * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5427|5427]] * **UniProt**: [[https://www.uniprot.org/uniprot/P56282|P56282]] * **Interactions**: [[https://thebiogrid.org/search.php?search=POLE2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20POLE2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602670|Open OMIM]] == Function Summary == * **Entrez Summary**: DNA polymerase epsilon, which is involved in DNA repair and replication, is composed of a large catalytic subunit and a small accessory subunit. The protein encoded by this gene represents the small subunit (B). Defects in this gene have been linked to colorectal cancer and to combined immunodeficiency. [provided by RefSeq, Jan 2017]. * **UniProt Summary**: Participates in DNA repair and in chromosomal DNA replication. |DNA pol E B| |Dpoe2NT| |epsilon DNA polymerase complex| |error-prone translesion synthesis| |telomere maintenance via semi-conservative replication| |DNA-directed DNA polymerase activity| |DNA replication initiation| |translesion synthesis| |nuclear DNA replication| |cell cycle DNA replication| |DNA synthesis involved in DNA repair| |postreplication repair| |telomere maintenance| |telomere organization| |DNA biosynthetic process| |G1/S transition of mitotic cell cycle| |DNA-dependent DNA replication| |cell cycle G1/S phase transition| |DNA replication| |mitotic cell cycle phase transition| |cell cycle phase transition| |nuclear body| |anatomical structure homeostasis| |DNA repair| |mitotic cell cycle process| |mitotic cell cycle| |intracellular membrane-bounded organelle| |DNA metabolic process| |cellular response to DNA damage stimulus| |cellular homeostasis| |cell cycle process| |chromosome organization| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |cell cycle| |DNA binding| |cellular nitrogen compound biosynthetic process| |homeostatic process| |cellular response to stress| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp532|TIC10 10μM R08 exp532]]|-2.04| |[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|-1.97| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-1.71| |[[:results:exp426|FBS-Wisent 0.1 R07 exp426]]|1.73| |[[:results:exp271|CCT251545 0.2μM R06 exp271]]|1.77| |[[:results:exp220|BAY-598 4μM R05 exp220]]|1.84| |[[:results:exp156|UNC2400 2μM R03 exp156]]|1.84| |[[:results:exp348|Cyclosporin-A 3μM R07 exp348]]|1.9| |[[:results:exp216|Erlotinib 10μM R05 exp216]]|1.93| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|2.02| |[[:results:exp237|NN-Diethyl-meta-toluamide 100μM R05 exp237]]|2.14| |[[:results:exp432|YM155 0.001μM R08 exp432]]|2.15| |[[:results:exp101|Nicotinamide 1000μM R03 exp101]]|2.16| |[[:results:exp476|Dihydrosphingosine 8μM R08 exp476]]|2.17| |[[:results:exp344|Chlorpromazine 10μM R07 exp344]]|2.24| |[[:results:exp362|GSK-J4 1μM R07 exp362]]|2.25| |[[:results:exp506|Momordin-Ic 10μM R08 exp506]]|2.25| |[[:results:exp457|Bisphenol F 50μM R08 exp457]]|2.42| |[[:results:exp351|Dexamethasone 0.006μM R07 exp351]]|2.42| |[[:results:exp326|CCT251545 20μM R07 exp326]]|2.46| |[[:results:exp308|Rapamycin 2μM plus FK-506 5μM R07 exp308]]|2.54| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|2.59| |[[:results:exp248|UM0131023 0.05μM R05 exp248]]|2.78| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.482| |[[:human genes:i:iscu|ISCU]]|0.458| |[[:human genes:p:psmb4|PSMB4]]|0.45| |[[:human genes:o:orc1|ORC1]]|0.446| |[[:human genes:r:rps12|RPS12]]|0.442| |[[:human genes:t:terf1|TERF1]]|0.429| |[[:human genes:s:sf3a1|SF3A1]]|0.424| |[[:human genes:c:cbwd5|CBWD5]]|0.416| |[[:human genes:t:tceb3c|TCEB3C]]|0.409| |[[:human genes:c:chd4|CHD4]]|0.406| |[[:human genes:n:nupl1|NUPL1]]|0.405| |[[:human genes:c:cbwd6|CBWD6]]|0.404| |[[:human genes:t:tceb3cl2|TCEB3CL2]]|0.403| |[[:human genes:i:igfn1|IGFN1]]|0.401| |[[:human genes:t:tfip11|TFIP11]]|0.4| Global Fraction of Cell Lines Where Essential: 738/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|27/28| |blood|28/28| |bone|26/26| |breast|33/33| |central nervous system|56/56| |cervix|4/4| |colorectal|17/17| |esophagus|13/13| |fibroblast|1/1| |gastric|16/16| |kidney|21/21| |liver|20/20| |lung|75/75| |lymphocyte|16/16| |ovary|26/26| |pancreas|24/24| |peripheral nervous system|16/16| |plasma cell|15/15| |prostate|1/1| |skin|24/24| |soft tissue|9/9| |thyroid|2/2| |upper aerodigestive|22/22| |urinary tract|29/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 114 * **Expression level (log2 read counts)**: 5.43 {{:chemogenomics:nalm6 dist.png?nolink |}}